Literature DB >> 2541600

Prostaglandins promote osteoclastlike cell formation by a mechanism involving cyclic adenosine 3',5'-monophosphate in mouse bone marrow cell cultures.

T Akatsu1, N Takahashi, K Debari, I Morita, S Murota, N Nagata, O Takatani, T Suda.   

Abstract

We have developed a mouse bone marrow culture system in which multinucleated osteoclast (OC)-like cells are formed within 8 days. Using this culture system, we examined the effect of prostaglandins (PGs), potent bone-resorbing agents, on OC-like cell formation. Four PGs (PGE1 and PGE2 at 10(-8)-10(-5) M, 6-keto-PGF1 alpha at 10(-5) M, and PGF2 alpha at 10(-6)-10(-5) M) significantly stimulated the formation of OC-like cells. The potency of the PGs in inducing OC-like cell formation was the highest in PGE1 and PGE2, followed by PGF2 alpha and 6-keto-PGF1 alpha in that order, and the order was highly correlated with the order of the potency in increasing the production of cyclic adenosine 3',5'-monophosphate (cAMP) in bone marrow cells. Addition of dibutyryl-cAMP also induced OC-like cell formation. Moreover, isobutylmethylxanthine (IBMX), a potent inhibitor of phosphodiesterase, potentiated the OC-like cell formation induced by PGE2, whereas salmon calcitonin greatly inhibited it. Calcitonin induced cAMP production in cultures treated with PGE2, but not in cultures with vehicle. When bone marrow mononuclear cells were cultured on dentine slices in the presence of PGE2, multinucleated OC-like cells were similarly formed and they resorbed calcified dentine, resulting in so-called Howship's lacunae. These results suggest that PGs stimulate resorption of calcified tissues by promoting osteoclast formation. The activity of PGs in inducing OC-like cell formation is considered mediated mainly by a mechanism involving cAMP.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2541600     DOI: 10.1002/jbmr.5650040106

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  18 in total

1.  Cadmium stimulates osteoclast-like multinucleated cell formation in mouse bone marrow cell cultures.

Authors:  T Miyahara; M Takata; M Miyata; M Nagai; A Sugure; H Kozuka; S Kuze
Journal:  Bull Environ Contam Toxicol       Date:  1991-08       Impact factor: 2.151

2.  Combined zoledronic acid and meloxicam reduced bone loss and tumour growth in an orthotopic mouse model of bone-invasive oral squamous cell carcinoma.

Authors:  C K Martin; W P Dirksen; M M Carlton; L G Lanigan; S P Pillai; J L Werbeck; J K Simmons; B E Hildreth; C A London; R E Toribio; T J Rosol
Journal:  Vet Comp Oncol       Date:  2013-05-08       Impact factor: 2.613

3.  Lysophosphatidic acid stimulates osteoclast fusion through OC-STAMP and P2X7 receptor signaling.

Authors:  Young Sun Hwang; Gwang-Taek Ma; Kwang-Kyun Park; Won-Yoon Chung
Journal:  J Bone Miner Metab       Date:  2013-04-27       Impact factor: 2.626

4.  Giant cell tumor of bone: a neoplasm or a reactive condition?

Authors:  Anwar Ul Haque; Ambreen Moatasim
Journal:  Int J Clin Exp Pathol       Date:  2008-01-01

Review 5.  Prostaglandins: mechanisms of action and regulation of production in bone.

Authors:  L G Raisz; C C Pilbeam; P M Fall
Journal:  Osteoporos Int       Date:  1993       Impact factor: 4.507

6.  Establishment and characterization of stromal cell lines that support differentiation of murine hematopoietic blast cells into osteoclast-like cells.

Authors:  H Takanashi; T Matsuishi; K Yoshizato
Journal:  In Vitro Cell Dev Biol Anim       Date:  1994-06       Impact factor: 2.416

7.  An assessment of the ability of human bone marrow cultures to generate osteoclasts.

Authors:  A M Flanagan; M A Horton; E L Dorey; D A Collins; R S Evely; J M Moseley; F C Firkin; T J Chambers; M H Helfrich; T J Martin
Journal:  Int J Exp Pathol       Date:  1992-06       Impact factor: 1.925

8.  Actinobacillus actinomycetemcomitans Y4 capsular-polysaccharide-like polysaccharide promotes osteoclast-like cell formation by interleukin-1 alpha production in mouse marrow cultures.

Authors:  T Nishihara; N Ueda; K Amano; Y Ishihara; H Hayakawa; T Kuroyanagi; Y Ohsaki; K Nagata; T Noguchi
Journal:  Infect Immun       Date:  1995-05       Impact factor: 3.441

9.  Soluble interleukin-6 receptor triggers osteoclast formation by interleukin 6.

Authors:  T Tamura; N Udagawa; N Takahashi; C Miyaura; S Tanaka; Y Yamada; Y Koishihara; Y Ohsugi; K Kumaki; T Taga
Journal:  Proc Natl Acad Sci U S A       Date:  1993-12-15       Impact factor: 11.205

10.  The role of 1,25-dihydroxycholecalciferol and prostaglandin E2 in the regulation of human osteoclastic bone resorption in vitro.

Authors:  A M Flanagan; M D Stow; N Kendall; W Brace
Journal:  Int J Exp Pathol       Date:  1995-02       Impact factor: 1.925

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.